首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Predicting Local Failure after Stereotactic Radiation Therapy in Brain Metastasis using Quantitative CT and Machine Learning*
【24h】

Predicting Local Failure after Stereotactic Radiation Therapy in Brain Metastasis using Quantitative CT and Machine Learning*

机译:使用定量CT和机器学习预测在脑转移中进行立体定向放射治疗后的局部失败*

获取原文

摘要

Despite recent advances in cancer treatment, the prognosis of patients diagnosed with brain metastasis is still poor. The median survival is limited to months even for patients undergoing treatment. Radiation therapy is a main component of treatment for brain metastasis. However, radiotherapy cannot control local progression in up to 20% of the metastatic brain tumours. An early prediction of radiotherapy outcome for individual patients could facilitate therapy adjustments to improve its efficacy. This study investigated the potential of quantitative CT biomarkers in conjunction with machine learning methods to predict local failure after radiotherapy in brain metastasis. Volumetric CT images were acquired for radiation treatment planning from 120 patients undergoing stereotactic radiotherapy. Quantitative features characterizing the morphology and texture were extracted from different regions of each lesion. A feature reduction/selection framework was adapted to define a quantitative CT biomarker of radiotherapy outcome. Different machine learning methods were applied and evaluated to predict the local failure outcome at pre-treatment. The optimum biomarker consisting of two features in conjunction with an AdaBoost with decision tree could predict the local failure outcome with 71% accuracy on an independent test set (20 patients, 31 lesions). This study is a step forward towards prediction of radiotherapy outcome in brain metastasis using quantitative imaging and machine learning.
机译:尽管最近在癌症治疗方面取得了进展,但是诊断为脑转移的患者的预后仍然很差。即使对于接受治疗的患者,中位生存期也仅限于数月。放射治疗是脑转移治疗的主要组成部分。但是,放射疗法无法控制多达20%的转移性脑肿瘤的局部进展。对个别患者进行放射治疗结果的早期预测可能有助于调整治疗方法,以提高疗效。这项研究调查了定量CT生物标记物与机器学习方法相结合的潜力,从而预测了脑转移放疗后的局部衰竭。从120例接受立体定向放射治疗的患者中获取了体积CT图像以进行放射治疗计划。从每个病变的不同区域提取表征形态和质地的定量特征。特征减少/选择框架适用于定义放射治疗结果的定量CT生物标志物。应用了不同的机器学习方法并进行了评估,以预测预处理过程中的局部失败结果。包含两个功能的最佳生物标志物以及带有决策树的AdaBoost可以在独立测试集(20例患者,31个病灶)上以71%的准确度预测局部失败的结果。这项研究是使用定量成像和机器学习朝预测脑转移放疗结果迈出的一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号